C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
12/2004
12/09/2004	DE10323692A1 Chirale Liganden und deren Übergangsmetallkomplexe Chiral ligands and their transition metal complexes
12/08/2004	EP1484301A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
12/08/2004	EP1482924A2 Cathepsin cysteine protease inhibitors
12/08/2004	CN1553899A Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor and medicinal composition containing the same
12/08/2004	CN1178938C 1,2-annelated quinoline derivatives
12/08/2004	CN1178927C Histamine H3 receptor ligands
12/07/2004	US6828329 Aryl fused substituted 4-oxy-pyridines
12/07/2004	US6828316 Antiallergens
12/02/2004	WO2004104014A2 Chiral ligands and their transition metal complexes
12/02/2004	WO2004103998A1 Quinoline derivatives as phosphodiesterase inhibitors
12/02/2004	WO2004103973A1 Phenyl quinolines and their use as estrogen receptor modulators
12/02/2004	WO2004058174A3 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/02/2004	WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors
12/02/2004	US20040242928 Reverse hydroxamic acid derivatives
12/02/2004	US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004	US20040242632 Method for treating inflammatory bowel disease
12/02/2004	US20040242630 Dichlorinated heterocyclic compounds and methods of synthesis
12/02/2004	US20040242615 enhancing the expression of apoAI; prevention or therapy of dislipidemia
12/02/2004	US20040242603 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor and medicinal composition containing the same
12/02/2004	US20040241495 photoresist grid has an array of pixels, each with an emissive layer consisting of tris(1-phenylpyridyl) irridium or tris(1-phenylisoquinoline) irridium; shrinkage inhibition
12/02/2004	CA2525292A1 Phenyl quinolines and their use as estrogenic agents
12/01/2004	EP1481965A1 Aromatic amino acid derivatives and medicinal compositions
12/01/2004	EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004	EP1480974A1 Heterocyclylmethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors
12/01/2004	EP1480972A2 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
12/01/2004	EP1480954A1 Vanilloid receptor modulators
12/01/2004	EP1480953A1 Process for preparing aripiprazole
12/01/2004	EP1480628A1 Use of sodium/hydrogen exchange inhibitors for the treatment of thrombotic and inflammatory diseases
12/01/2004	EP1480615A1 Formoterol superfine formulation
12/01/2004	EP1246625B1 Uses and compositions of nitrate esters for providing sedation
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	EP0886637B1 Inhibitors of microsomal triglyceride transfer protein and method
12/01/2004	CN1551769A Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
12/01/2004	CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004	CN1177834C Dihydroxyhexanoic acid derivatives
11/2004
11/30/2004	US6826033 Beta 3 adrenergic receptor agonists; treatment of pollakiuria, urinary incontinence, obesity or diabetes
11/30/2004	US6825354 Osteoporosis; rheumatic diseases
11/30/2004	US6825353 Process for producing quinolonecarboxylic acids and intermediates thereof
11/30/2004	US6825351 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (r)- and (s)-forms
11/30/2004	US6825217 Heterocyclic amines such as 4-(3'-thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
11/30/2004	US6825215 1,1-disubstituted cyclic inhibitors of matrix metalloproteases and TNF-α
11/30/2004	US6825189 Treating withdrawal symptoms caused by smoking cessation
11/30/2004	CA2251795C Novel n-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands
11/25/2004	WO2004101544A1 Benzyl sulfonamide derivatives as androgen receptor antagonists
11/25/2004	WO2004101530A1 A method for producing diverse set of dithioate compounds
11/25/2004	WO2004101527A1 Process for preparing omega-anhydrous gatifloxacin
11/25/2004	WO2004101526A1 Polymorphous crystal of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-qunolinecarboxamide and method for preparation thereof
11/25/2004	WO2004101525A1 Crystalline form of aryl aniline beta-2 adrenergic receptor agonist
11/25/2004	WO2004074255A3 Method for producing an optically active tetrahydroquinoline
11/25/2004	WO2004050657A3 COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE
11/25/2004	US20040236109 Tetrahydroquinoline derivatives
11/25/2004	US20040235938 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/25/2004	US20040235911 hydroxyamidines; antibiotic resistance
11/25/2004	US20040235910 Mutilin derivatives and their use as antibacterials
11/25/2004	US20040235877 Novel use of tricyclic compound
11/25/2004	US20040235848 Phenylalanine derivatives
11/25/2004	US20040235847 For therapy of thromboembolic and/or inflammatory disorders
11/25/2004	US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004	US20040235823 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor
11/25/2004	US20040234958 Surface enhanced (resonance) Raman scattering with 2,4,6-trinitrostyryl-1H-benzotriazole; for detection of explosives and drugs; drug screening
11/25/2004	US20040234622 Sulfonamide derivatives
11/25/2004	DE10320453A1 Neue Bioisostere von Actinonin New bioisosteres of Actinonin
11/25/2004	CA2525862A1 Process for preparing omega-anhydrous gatifloxacin
11/25/2004	CA2524434A1 Benzyl sulfonamide derivatives as androgen receptor antagonists
11/24/2004	EP1478642A1 Synthesis of gatifloxacin
11/24/2004	EP1478640A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
11/24/2004	EP1478627A1 Method
11/24/2004	EP1478626A2 Guanidino compounds
11/24/2004	CN1176921C Semi-hydrochloride of 8-cyan-1-cyclopropyl-7-(1S-2,8-diazabicyclo [4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
11/24/2004	CN1176654C Quinolinone derivative preparations and process for producing same
11/23/2004	US6822102 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of COX-2 mediated disorders
11/23/2004	US6822098 Carbocyclic carbo, oxo amines such as n-heptyl-3-methyl-4-oxo -1,4-dihydroquinoline-2-carboxamide, used for prophylaxis of gastrointerstinal disorders
11/23/2004	US6822096 Colorimetric analysis; reversible adsorption/desorption of vapor of acetonitrile or ethanol; red/infrared change in luminescence
11/23/2004	US6821988 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
11/23/2004	US6821967 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9h-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
11/23/2004	US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/23/2004	US6821962 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases
11/23/2004	CA2329788C Quinoline derivatives
11/23/2004	CA2171446C Pseudo- and non-peptide bradykinin receptor antagonists
11/18/2004	WO2004099179A1 Piperazine-alkyl-ureido derivatives
11/18/2004	WO2004099151A1 Method for producing the purest rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl] piperazin-1-yl}-2,2-diphenylethan-1-one fumarate and the purest rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl]piperazin-1-yl}-2,2-diphenylethan-1-one fumarate
11/18/2004	WO2004099150A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/18/2004	WO2004099124A2 Novel bioisosteres of actinonin
11/18/2004	US20040230072 Phosphodiesterase 4 inhibitors
11/18/2004	US20040229955 Antibacterial agents
11/18/2004	US20040229922 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
11/18/2004	US20040229910 Therapeutic compounds
11/18/2004	US20040229907 2-Aminoquinolinecarboxamides: neurokinin receptor ligands
11/18/2004	US20040229906 Dichlorinated heterocyclic compounds and methods of synthesis
11/18/2004	US20040229880 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-3-quinolinecarbonitriles for the treatment of ischemic injury
11/18/2004	US20040229870 Certain alkylene diamine-substituted heterocycles
11/18/2004	US20040229860 For enhancing bone formation; for therapy of diseases or disorders associated with abnormal bone or mineral homeostasis
11/18/2004	US20040229847 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/18/2004	CA2526904A1 Blockers of the quorum sensing system of gram-negative bacteria
11/18/2004	CA2524621A1 Method for producing the purest rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl] piperazin-1-yl}-2,2-diphenylethan-1-one fumarate and the purest rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl]piperazin-1-yl}-2,2-diphenylethan-1-one fumarate
11/18/2004	CA2523566A1 Piperazine-alkyl-ureido derivatives
11/18/2004	CA2523235A1 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/17/2004	EP1477186A1 Antipruritics
11/17/2004	EP1476429A1 Novel pyridine- and quinoline-derivatives
11/17/2004	EP1476161A1 Piperidine and piperazine derivatives possessing affinity at 5ht-1 type receptors

1 ... 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 ... 277